Karel Ulbrich
- Biomaterials top 0.02%
- Molecular Biology top 0.5%
- Biomedical Engineering top 0.2%
- Organic Chemistry top 0.5%
- Polymers and Plastics top 0.5%
- Co-authors
- Vladimír ŠubrTomáš EtrychJ. StrohalmLeonard W. SeymourBlanka Řı́hováČestmı́r KoňákJindřich KopečekPetr Chytil
- Topics
- Nanoparticle-Based Drug Delivery (124 papers)RNA Interference and Gene Delivery (71 papers)Nanoplatforms for cancer theranostics (46 papers)
- Partner nations
- CzechiaUnited KingdomGermany
In The Last Decade
Karel Ulbrich
308 papers receiving 17.1k citations
Hit Papers
Peers
Comparison fields: 5 of 149
- Biomaterials 8.6k
- Molecular Biology 7.3k
- Biomedical Engineering 5.4k
- Organic Chemistry 3.6k
- Polymers and Plastics 2.3k
Countries citing papers authored by Karel Ulbrich
This map shows the geographic impact of Karel Ulbrich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karel Ulbrich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karel Ulbrich more than expected).
Fields of papers citing papers by Karel Ulbrich
This network shows the impact of papers produced by Karel Ulbrich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karel Ulbrich. The network helps show where Karel Ulbrich may publish in the future.
Co-authorship network of co-authors of Karel Ulbrich
This figure shows the co-authorship network connecting the top 25 collaborators of Karel Ulbrich. A scholar is included among the top collaborators of Karel Ulbrich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Karel Ulbrich. Karel Ulbrich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 83 | |
| 2 | 57 | |
| 3 | 31 | |
| 4 | Polymer drug carriers with enhanced penetration into tumor cells | 0 |
| 5 | 62 | |
| 6 | 18 | |
| 7 | 9 | |
| 8 | 41 | |
| 9 | Development of hydrophilic polymers to reduce the interaction of adenovirus type 5 with human blood components | 1 |
| 10 | 103 | |
| 11 | 107 | |
| 12 | 44 | |
| 13 | 23 | |
| 14 | Enzymatically degradable PEG multiblock copolymers with hydrazone-attached doxorubicin in cancer therapy. | 10 |
| 15 | 114 | |
| 16 | 27 | |
| 17 | 370 | |
| 18 | 42 | |
| 19 | 94 | |
| 20 | 177 |
About Karel Ulbrich
Karel Ulbrich is a scholar working on Biomaterials, Molecular Medicine and Polymers and Plastics, having authored 310 papers that have together received 17.4k indexed citations. Recurring topics across this work include Nanoparticle-Based Drug Delivery (124 papers), RNA Interference and Gene Delivery (71 papers) and Nanoplatforms for cancer theranostics (46 papers). The work is most often cited by research in Biomaterials (8.6k citations), Molecular Medicine (1.0k citations) and Polymers and Plastics (2.3k citations). Karel Ulbrich has collaborated with scholars based in Czechia, United Kingdom and Germany. Frequent co-authors include Vladimír Šubr, Tomáš Etrych, J. Strohalm, Leonard W. Seymour, Blanka Řı́hová, Čestmı́r Koňák, Jindřich Kopeček, Petr Chytil, Ruth Duncan and M. Jelı́nková. Their work appears in journals such as Chemical Reviews, Journal of Biological Chemistry and Angewandte Chemie International Edition.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.